Lindsay Cardinal Murphy’s Post

ON-DEMAND WEBINAR: Equitable Solutions to Increase BCS Across Diverse Populations   Join mPulse’s SriVani Ganti, MSHC Ganti, Director of Health Equity, and Eden Brownell 👩🏼🏫, Director of Behavioral Science, to learn how health organizations can increase breast cancer screening completions by delivering equitable digital engagement solutions to overcome barriers across diverse populations. By leveraging Conversational AI and Natural Language Understanding (NLU), health organizations can meet their consumers where they are. Watch the webinar here: https://lnkd.in/g7ZjQYPi

The broader impact of Bias in AI! Yesterday, I had an electrifying experience attending the seminar “Avoiding bias in AI” at the Swiss Institute for Translational and Entrepreneurial Medicine (sitem-insel). #oncology, #medicaldevice, #AI, #innovation, #entrepreneurship #bigdata. I can't express enough how inspired I was by the incredible lineup of speakers in this unique space. Berna Özdemir's talk (Bern University Hospital and #ESMO Gender Medicine Task Force) left me speechless. Her research is a must-know for medical affairs professionals in oncology. Gender bias in cancer research, from cell lines to clinical trials, impacts treatment guidelines. The failure of our research to reveal sex differences in the toxicity and efficacy of cancer therapies can have life-threatening effects. Let's have the courage to spread the word and shake things up. Congratulations to Virginia Richter, who will become the first woman Rector of the University of Bern this year and who opened the event with a fantastic lecture. Saniye Güsler Corat, co-founder of NoBiasAI? and past Director for Gender Equality at #UNESCO, truly raised my awareness. Take a moment to understand the broader social impact of the seductive female persona of our popular AI assistants. It is presented in her research under the title "I’d blush if I could", published at unesco.org. Serife Seda Kucor, founder of PeriVision, showcased her incredible medical device using virtual reality goggles to diagnose and monitor glaucoma, the leading cause of irreversible blindness worldwide. This device saves time, money, and improves patient comfort. Given the vast unmet medical need globally and the portability of this device, a major cause of blindness could be better diagnosed, monitored, and treated everywhere. Big shoutout to Enriqueta Vallego-Yagüe, pharmacoepidemiologist at BIHAM, for shedding light on gender influences on health data. Awareness of these influences is crucial when applying AI to big data. This event was part of a series open to innovators interested in entrepreneurship, organized by the ARTORG Center for Biomedical Engineering Research and the Center for AI in Medicine. Feeling grateful for the opportunity to attend! #innovation #startup.

We have some great news to share from some of our members! 🚨 Simprints was recently named one in Newsweek’s Global Most Loved Workplaces of 2024 list. Beyond just the considerations of pay and benefits, the organizations named lead in terms of employee satisfaction, workplace culture and providing the tools for employees to do their best work. Learn more: https://lnkd.in/dvAmV_C4 Roche recently obtained approval from the U.S. Food and Drug Administration for its human papillomavirus (HPV) self-collection solution, calling it "one of the first available in the United States." The company said screening for HPV can help identify women at risk of developing cervical cancer so the disease can be found and patients can receive early treatment. Learn more: https://lnkd.in/gHGmF3FH Boston Consulting Group (BCG) recently announced it has entered a strategic collaboration with Merck, which will leverage artificial intelligence (AI) and generative artificial intelligence (GenAI) to potentially enable the discovery and assessment of novel drug targets. As part of the collaboration, BCG X (the tech build and design unit of BCG) will work with Merck to develop algorithms that use AI to mine robust omics data in an effort to better understand causal relationships between biomarkers and disease biology to facilitate drug target discovery. Learn more: https://lnkd.in/g2c9ZaMg

Atropos Health is bringing together real-world evidence (RWE) and artificial intelligence (AI) to close the evidence gap in healthcare. The recent fundraise allows us to accelerate our strategy and engage key channel partners and customers, expand our presence in Life Sciences, continue to grow data and partners on the Atropos Evidence™ Network, and prepare to launch ChatRWD™. Our technology, starting with GENEVA OS™ (Generative Evidence Acceleration Operating System), can quickly answer clinical questions, such as which drug is most effective for certain cancer patients. "The same thing that lets us bring that answer back to a doctor also accelerates everything pharma is doing, all the way through R&D with real-world data into medical and commercial." said CEO and co-Founder Dr. Brigham Hyde. Data researchers leverage Atropos Health to help accelerate clinical development with real-world data analysis in oncology and other specialty areas. Oncologists and researchers can leverage the Atropos Evidence™ Network to inform their clinical decision-making process. Read more from Heather Landi at FierceHealthcare https://hubs.li/Q02yjMdD0 #AtroposHealth #RealWorldEvidence #HealthcareInnovation #SeriesBFunding #HealthTech #PharmaPartnerships #OncologyResearch #MedicalResearch #ClinicalDevelopment #GenerativeAI #healthcareAI #AIinhealthcare #RWE

Big data is everywhere, and how we can use it to improve cancer care is the challenge we have faced for over a decade! Are we getting closer to making it quick and easy to solve for our patients? Fantastic article in Cell Press by #XifengWu and Huakang Tu Link: https://lnkd.in/gNHcQXQs Precision Oncology's Leap 🎯: AI and Big Data 💾 are reshaping cancer care 🩺, offering personalized treatments from a vast pool of data types 📊. This means more accurate diagnoses 🎯 and tailored therapies for better patient outcomes ❤️. Navigating Challenges 🔍: Despite hurdles like data privacy 🔒 and integration challenges, innovative solutions employing machine learning 🤖 and advanced data management 📈 ensure clinicians have reliable, secure data for decision-making. Collaborative Future 🌍: The journey ahead is exciting, with AI guiding intelligent health management platforms 🏥. Embracing interdisciplinary collaboration 🤝 will unlock new treatments 💊 and elevate patient care 🚀. Can i be honest, its complicated on what is happening in #healthcareAI. I certainly need to find time to read this carefully and understand its importance. If you are interested in saving your time, follow our newsletter. We make it simple for you https://lnkd.in/gJiFqA8j

Pfizer’s approach to integrating AI, specifically through the use of Meta's TinyLLaMA model, along with open-source LLM model RoBERTa-Squad2, knowledge graphs and RAG, resulted in monumental efficiency gains. With tasks previously taking 9 months now completed in 10 minutes, and a $5.3 million annual savings, Pfizer has revolutionized their document management processes, achieving a 90% reduction in manual work. This shows the power of AI in streamlining complex workflows, allowing the company to focus on innovation and higher-value tasks. And if this works for Pfizer, this method can be applied for your company! 🚀 At Stanmango HR, we understand that finding top talent can be just as intricate as managing vast datasets. We are here to help you source the best candidates, faster and more efficiently, using our technology to keep you ahead of the competition. 💼 Thanks to Lewis, you'll find a nice infographic as an explanation of which method was used by AI engineers at Pfizer in the first comment. #AIRecruitment #TopAITalents #RAG #RecruitSmarter #StanmangoRH https://lnkd.in/eUA6BjCC https://lnkd.in/e-fgYQaA

Well done to all participants in this excellent Nudgeathon. This UCL Behavioural Innovations Society and LSESU Behavioural and Psychological Science Society event showcased opportunities for the real world application of #BehaviouralScience in designing global health solutions. It was a pleasure to have been part of the judging panel. For those not yet familiar with the concept, a nudgeathon is a behavioural science based #hackathon It presents an existing challenge or 'wicked problem' and tasks participants (often students) with applying behavioural science in designing solutions. The challenge here, presented by UNICEF, was to support an increase in HPV vaccine uptake. This is a brilliant process for generating theory underpinned, creative solutions that harnesses knowledge to shape practice in a 48hr turnaround. Public behaviour, customer choice, staff decision making...can you think of a challenge your work is facing that might benefit from this approach? #PolicyDesign #BehaviourChange #BehaviouralInsights #nudge

With ASCO just around the corner, it's clear how pivotal this event is for advancing oncology research and practice. To ensure you receive the most insightful updates and analyses, my team is thrilled to offer our advanced Congress Intelligence services. Our congress reports leverage social media and other sources to synthesize meaningful trends and insights, all with an eye toward helping you optimize your medical strategy and make informed decisions. Worth noting: our integration of cutting-edge AI-powered tools into these analyses allows us to provide more in-depth and predictive influencer analyses.   Our Congress Intelligence report includes:  - Share of voice: Quantitative overview of conversation volume on key data presentations during the meeting  - Key influencers: Digital opinion leaders driving discussion during the congress, as determined by Real Chemistry’s proprietary influencer algorithms  - Clinical sentiment: Perceptions and opinions on asset and competitor data presentations, powered by AI tools and validated by trained medical affairs strategists and linguistics experts   - Strategic implications and recommendations: Summary of key actionable insight themes, together with implications and opportunities, to inform medical strategy Interested in learning more? For a deeper dive into our services and to explore how we can specifically support your needs at ASCO, please send me a direct message to connect. #ASCO2024 #Oncology #MedicalAffairs #HealthcareInnovation #DataIntelligence

My colleagues cover the opportunities in #oncology to apply #AI to support diagnostics, predictive analytics, and administrative functions. Check out the full blog post below. #lifesciences

My colleagues cover the opportunities in #oncology to apply #AI to support diagnostics, predictive analytics, and administrative functions. Check out the full blog post below. #lifesciences